Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | CCR8 | P51685 | 1/20 | 0.35 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.32 |
| ▸ | CDK1 | P06493 | 3/20 | 0.32 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.32 |
| ▸ | GSK3A | P49840 | 3/20 | 0.32 |
| ▸ | GSK3B | P49841 | 3/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.32 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10293912 | 0.81 | HSP90AA1 (0.46) | NPC1HSP90AA1L3MBTL1CCR1CCR5 | |
| SCHEMBL21297747 | 0.78 | HSP90AA1 (0.43) | NPC1HSP90AA1L3MBTL1CCR1CCR5 | |
| SCHEMBL11790193 | 0.78 | HSP90AA1 (0.43) | NPC1HSP90AA1L3MBTL1CCR1CCR5 | |
| SCHEMBL30829747 | 0.74 | HTT (0.37) | NPC1HSP90AA1L3MBTL1 | |
| SCHEMBL28892659 | 0.74 | HTT (0.37) | NPC1HSP90AA1L3MBTL1 | |
| SCHEMBL30829720 | 0.74 | NPC1 (0.33) | NPC1HSP90AA1L3MBTL1CCR1CCR5 | |
| SCHEMBL28892165 | 0.74 | NPC1 (0.33) | NPC1HSP90AA1L3MBTL1CCR1CCR5 | |
| SCHEMBL19104618 | 0.72 | CCR1 (0.33) | NPC1HSP90AA1L3MBTL1CCR1CCR5 | |
| SCHEMBL14380265 | 0.72 | — | — | |
| SCHEMBL27713680 | 0.71 | KDM4E (0.30) | HSP90AA1L3MBTL1CCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9376529-B2 | Fluoro monomers, oligomers, and polymers for inks and organic electronic devices | SOLVAY USA INC. (US) | 2016-06-28 | — | — | US | disclosed |
| US-9376529-B2 | Fluoro monomers, oligomers, and polymers for inks and organic electronic devices | SOLVAY USA INC. (US) | 2016-06-28 | — | — | US | disclosed |
| US-20140338750-A1 | ORGANIC PHOTOELECTRIC CONVERSION ELEMENT | Konica Minolta, Inc. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20120152357-A1 | FLUORO MONOMERS, OLIGOMERS, AND POLYMERS FOR INKS AND ORGANIC ELECTRONIC DEVICES | PLEXTRONICS, INC. | 2012-06-21 | — | — | US | disclosed |
| US-20120152357-A1 | FLUORO MONOMERS, OLIGOMERS, AND POLYMERS FOR INKS AND ORGANIC ELECTRONIC DEVICES | PLEXTRONICS, INC. | 2012-06-21 | — | — | US | disclosed |
| WO-2012082893-A2 | FLUORO MONOMERS, OLIGOMERS, AND POLYMERS FOR INKS AND ORGANIC ELECTRONIC DEVICES | PLEXTRONICS, INC. (US) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120152357-A1 | FLUORO MONOMERS, OLIGOMERS, AND POLYMERS FOR INKS AND ORGANIC ELECTRONIC DEVICES | ILK, VCL, NECTIN4 | NPC1 2378/4885HSP90AA1 4110/4885L3MBTL1 2158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.